TrademarkDir
IPSENCARES COVERAGE, ACCESS, REIMBURSEMENT & EDUCATION SUPPORT
LIVE

Serial Number

90206991

Owner

IPSEN S.A.

Attorney

Ben Natter

Filing Date

Sep 24, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IPSENCARES COVERAGE, ACCESS, REIMBURSEMENT & EDUCATION SUPPORT Trademark

Serial Number: 90206991 • Registration: 6667935

IPSENCARES COVERAGE, ACCESS, REIMBURSEMENT & EDUCATION SUPPORT is a trademark filed by IPSEN S.A. on September 24, 2020. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

IPSEN S.A. (46 trademarks)

65 QUAI GEORGES GORSE
BOULOGNE-BILLANCOURT 92100 , FR

Entity Type: 03

Trademark Details

Filing Date

September 24, 2020

Registration Date

March 8, 2022

Published for Opposition

July 6, 2021

Goods & Services

Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 29, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 29, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 29, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 29, 2025 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 1, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 30, 2022 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2022 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2022 CHAN
ASSIGNED TO LIE
Jan 27, 2022 ALIE
ASSIGNED TO LIE
Jan 27, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2022 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jan 20, 2022 EWOR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 11, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 11, 2022 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 6, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 30, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 30, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 30, 2021 COAR
STATEMENT OF USE PROCESSING COMPLETE
Dec 14, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 13, 2021 AITU
USE AMENDMENT FILED
Nov 12, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 12, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 31, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 16, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2021 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 16, 2021 GPRN
PRIORITY ACTION E-MAILED
Feb 16, 2021 GPRA
PRIORITY ACTION WRITTEN
Feb 16, 2021 CPRA
ASSIGNED TO EXAMINER
Feb 12, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2020 NWOS
NEW APPLICATION ENTERED
Sep 28, 2020 NWAP

Related Trademarks

More from this Owner

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE